Skip to Content
Merck
  • Italian consensus conference for colonic diverticulosis and diverticular disease.

Italian consensus conference for colonic diverticulosis and diverticular disease.

United European gastroenterology journal (2014-11-02)
Rosario Cuomo, Giovanni Barbara, Fabio Pace, Vito Annese, Gabrio Bassotti, Gian Andrea Binda, Tino Casetti, Antonio Colecchia, Davide Festi, Roberto Fiocca, Andrea Laghi, Giovanni Maconi, Riccardo Nascimbeni, Carmelo Scarpignato, Vincenzo Villanacci, Bruno Annibale
ABSTRACT

The statements produced by the Consensus Conference on Diverticular Disease promoted by GRIMAD (Gruppo Italiano Malattia Diverticolare, Italian Group on Diverticular Diseases) are reported. Topics such as epidemiology, risk factors, diagnosis, medical and surgical treatment of diverticular disease (DD) in patients with uncomplicated and complicated DD were reviewed by a scientific board of experts who proposed 55 statements graded according to level of evidence and strength of recommendation, and approved by an independent jury. Each topic was explored focusing on the more relevant clinical questions. Comparison and discussion of expert opinions, pertinent statements and replies to specific questions, were presented and approved based on a systematic literature search of the available evidence. Comments were added explaining the basis for grading the evidence, particularly for controversial areas.

MATERIALS
Product Number
Brand
Product Description

Mesalazine for system suitability, European Pharmacopoeia (EP) Reference Standard
Supelco
Mesalamine, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
5-Aminosalicylic acid, 95%
Sigma-Aldrich
5-Aminosalicylic acid, ≥99%
Mesalazine, European Pharmacopoeia (EP) Reference Standard